Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04109612
Other study ID # 15117
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 17, 2019
Est. completion date January 13, 2022

Study information

Verified date April 2022
Source National and Kapodistrian University of Athens
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The main objectives of the proposed project are: 1. To provide essential data on acute stroke management (quality indicators) incorporating hard clinical outcomes that will contribute to an ongoing process of quality improvement 2. To develop an interactive multichannel platform, for collecting, cleansing and curating high quality in-hospital and follow up data, applying multidimensional quality assessment analysis, providing statistical and analytic reports, monitoring behavioral changes and supporting overall project's management. 3. To evaluate patients' and physicians' experiences and their impact on stroke management. 4. To assess severe negative impact of stroke on the life of survivors including quality of life and disability 5. To measure health related and non- health (loss of productivity, informal care) related national expenditure for stroke care using a bottom up approach 6. To evaluate the value of care focusing on health outcomes compared with total costs of achieving them


Description:

A prospective cohort multicenter study of patients with first ever acute stroke, hemorrhagic and ischemic, (ICD-10 codes: I61, I63 and I64) admitted within 48 hours of symptoms onset to seven NHS and University hospitals will be conducted. About 1,000 patients (2% of all new cases/annually) will be recruited from six urban and semi-urban areas with 5.5 mil people (50% of Greek population), reporting 25,000 discharged stroke cases annually (53% of all stroke discharges), according to data derived from Hellenic Statistical Authority. All patients will be followed for three months. Moreover, a sub-group of the 300 firstly recruited patients will be followed for a year to obtain data on post hospital health and social needs, health services utilization (medication, rehabilitation, outpatient visits) and productivity loss . Patient enrolment and follow up is estimated to last 18 months.


Recruitment information / eligibility

Status Completed
Enrollment 913
Est. completion date January 13, 2022
Est. primary completion date October 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of hemorrhagic or ischemic stroke (ICD-10: I61, I63 and I64) - Patients with First ever acute stroke

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Greece Aiginiteio Hospital of Athens Athens
Greece General Hospital of Athens Alexandra Athens
Greece Hellenic Stroke Organization Athens
Greece Laiko General Hospital of Athens Athens
Greece National and Kapodistrian University of Athens Athens
Greece Chania General Hospital St George Chania
Greece University General Hospital of Ioannina Ioannina
Greece General University Hospital of Larisa Larisa
Greece University General Hospital of Thessaloniki Ahepa Thessaloniki
Greece General Hospital of Tripoli Evaggelistria Tripoli

Sponsors (4)

Lead Sponsor Collaborator
National and Kapodistrian University of Athens General Secretariat for Research and Technology, Hellenic Foundation for Research and Innovation, Hellenic Stroke Organization

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality Patient based stroke (inpatient and outpatient) mortality Through hospitalization completion, an average of 10 days
Primary Mortality Patient based stroke (inpatient and outpatient) mortality One month
Primary Mortality Patient based stroke (inpatient and outpatient) mortality Three months
Primary Modified Rankin Scale (mRS) score mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead) Through hospitalization completion, an average of 10 days
Primary Modified Rankin Scale (mRS) score mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead) One month
Primary Modified Rankin Scale (mRS) score mRS measures the degree of disability or dependence in the daily activities of patients after a stroke or other causes of neurological disability (0: no symptoms at all - 6: Dead) Three months
Primary National Institutes of Health Stroke Scale (NIHSS) score NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42:Severe Stroke) Through hospitalization completion, an average of 10 days
Primary National Institutes of Health Stroke Scale (NIHSS) score NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42: Severe Stroke) One month
Primary National Institutes of Health Stroke Scale (NIHSS) score NIHSS is a method for assessing the severity of a stroke experienced by a patient (0: No Stroke Symptoms, 42: Severe Stroke) Three months
Primary Cost Average cost per patient Through hospitalization completion, an average of 10 days
Primary Cost Average cost per patient One month
Primary Cost Average cost per patient Three months
See also
  Status Clinical Trial Phase
Completed NCT03239847 - Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring N/A
Recruiting NCT03544801 - Renji Cerebral Small Vessel Disease Corhort Study
Recruiting NCT06010823 - Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants N/A
Withdrawn NCT04991038 - Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients N/A
Recruiting NCT02472028 - Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals Phase 4
Completed NCT01915368 - Determining Optimal Post-Stroke Exercise (DOSE) N/A
Active, not recruiting NCT01555411 - Akershus Cardiac Examination (ACE) 1950 Study
Completed NCT01304576 - Orientation Agnosia: Clinical and Anatomical Study N/A
Completed NCT00059293 - Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
Completed NCT00049894 - Predictors of Recurrent Stroke in the PROGRESS Study N/A
Completed NCT00049920 - The ARIC MRI Study N/A
Completed NCT00005562 - Coronary Artery Calcium, Exercise Tests, and CHD Outcome N/A
Completed NCT00005395 - Honolulu Heart Program-Study of Stroke and Dementia N/A
Completed NCT00000479 - Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer Phase 3
Completed NCT00005140 - Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago N/A
Enrolling by invitation NCT00005485 - The Jackson Heart Study of Cardiovascular Disease Among African Americans
Recruiting NCT06275113 - BRING-UP Prevention
Completed NCT02702635 - Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging N/A
Recruiting NCT04336852 - Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function N/A
Not yet recruiting NCT05892510 - Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke Phase 2/Phase 3